Abstract
A correlation between phenotypical tumor characteristics, quantitative classical immunohistochemistry (IHC), and recurrence score (RS) from Oncotype DX results was used to develop a decision supporting system for clinical use. We created a freely available nomogram based on quantitative IHC results that allows prediction of RS ≤ 25 or ≤ 20. Prospective studies will test this application in clinical practice.
| Lingua originale | Inglese |
|---|---|
| pagine (da-a) | e600-e611 |
| Rivista | Clinical Breast Cancer |
| Volume | 20 |
| Numero di pubblicazione | 5 |
| DOI | |
| Stato di pubblicazione | Pubblicato - 2020 |
OSS delle Nazioni Unite
Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile
-
SDG 3 Salute e benessere
All Science Journal Classification (ASJC) codes
- Oncologia
- Ricerca sul Cancro
Keywords
- 80 and over
- Adjuvant chemotherapy
- Adult
- Aged
- Biomarkers
- Breast Neoplasms
- Breast cancer
- Decision supporting system
- Estrogen Receptor alpha
- Female
- Gene Expression Profiling
- Genetic Testing
- Health costs
- Humans
- Immunohistochemistry
- Ki-67 Antigen
- Local
- Middle Aged
- Neoplasm Recurrence
- Nomograms
- Progesterone
- Prognosis
- Quantitative IHC
- ROC Curve
- Receptors
- Retrospective Studies
- Tumor
Fingerprint
Entra nei temi di ricerca di 'Oncotype DX Predictive Nomogram for Recurrence Score Output: The Novel System ADAPTED01 Based on Quantitative Immunochemistry Analysis'. Insieme formano una fingerprint unica.Cita questo
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver